Home
About YESING
Company Profile
Company Business
International Business
R&D
Production
Delivery
Agent
Products
Medical Consumables
Medical Equipment
Medical Device
Reagent
Non Medical Devices
Solution
High-end medical consumable manufacturing
Smart Healthcare Device Integration Solution
End-to-End Diagnostic Reagent Solutions
Medical Gas Solutions
Blog
Industry Trends
Company News
Contact Us
Inquiry
Chinese
English
French
Russian
Japanese
Deepening China-Indonesia Cooperation in the Medical Supply Chain to Jointly Explore New Health Opportunities—Our Company Welcomes a Delegation from the Indonesian Government for an Inspection Visit.
2025-11-17
In the height of summer, on Lüdao Island, guests feel right at home. On June 30, against the backdrop of deepening medical cooperation between China and Indonesia under the Belt and Road Initiative and the RCEP framework, a medical delegation from the Indonesian government visited Xiamen. As a leading enterprise deeply rooted in the fields of medical devices, medical consumables, medical equipment, diagnostic reagents, and the global healthcare supply chain, our company was invited to engage in in-depth exchanges and discussions with the delegation, jointly exploring new avenues for industry collaboration.
Government and enterprises join forces to fight the epidemic and work together to embark on a new journey—our company has officially become a supplier of medical emergency supplies for Dehua County.
2023-12-27
When the epidemic struck, government and enterprises joined forces, demonstrating their sense of responsibility through mutual support and solidarity; we delved deeply into fertile ground to usher in a new chapter. Looking back at the critical period of epidemic prevention and control, Dehua County faced an urgent shortage of防疫 supplies, leaving many medical companies unable to provide adequate support. In this moment of crisis, our company stepped forward, proactively reaching out to the Dehua County government. With a strong sense of social responsibility and highly efficient supply-chain integration capabilities, we fully committed ourselves to ensuring the supply of防疫 materials.
Dedicated to Longyuan, Safeguarding Post-Disaster Well-being—Our Company Donates Protective Clothing for Epidemic Prevention to the Flood-Affected Areas in Gansu Province
2023-08-11
In 2023, many areas in Gansu Province were hit by severe flooding. The raging floods not only destroyed homes but also created hidden public health risks by spreading bacteria and viruses after the disaster. Though disasters are merciless, humanity remains compassionate. At this critical moment when epidemic prevention efforts in the affected areas are urgently needed, our company, guided by our original commitment to "medical care for the people and a sense of responsibility," proactively responded to the epidemic prevention needs of the disaster zone. We promptly allocated supplies and donated a batch of specialized protective suits to the flood-hit regions in Gansu, thereby establishing a strong safety barrier for frontline epidemic prevention workers in the aftermath of the disaster.
2023 Shenzhen International High-Performance Medical Device Exhibition | Thinker Medical Takes on Its Mission and Leads the Industry Toward High-Quality Development
2023-06-25
From June 8 to June 10, 2023, the Shenzhen International High-Performance Medical Device Exhibition was held with great success. ThinkMed Medical participated in several thematic seminars and forums at the exhibition, joining industry peers to discuss trends in the AI-driven healthcare sector and sharing its own innovative product applications as well as achievements in international expansion.
A Review of the Latest Globally Approved Medical Devices in May
2023-06-08
In May 2023, among globally approved medical devices, the FDA approved three products for the first time via the Premarket Approval (PMA) pathway. Domestically, four Class III medical devices were announced as entering the innovative approval green channel, and three innovative devices were approved for market launch. Among domestic medical device approvals, in vitro diagnostic reagents accounted for the largest share, totaling 1,040 items, or 33.56%.
The 6th China Digital Healthcare Innovation Summit
2023-04-06
In this era of rapid transformation in China’s healthcare market, how can medical enterprises strengthen their strategic positioning and support in areas such as digital healthcare, digital marketing, digital channels, and payment innovation? How can they build a closed-loop, end-to-end management system that integrates both hospital-to-hospital and online-to-offline approaches, and provide patients with comprehensive health management solutions?